The future of psychedelic medicines and healt...

Whether it’s micromanaging playtime, constantly hovering or incessantly texting, the adult takeover of childhood has created a crisis of anxiety in both children and parents. In this episode, Lenore Skenazy, cofounder and president Let Grow, an organization dedicated to normalizi ...  Show more

Bombarded with health headlines? Unsure how to discern fact from fiction? Social scientist Matthew Facciani breaks down identity politics and the psychology that shapes our most deeply held views. He discusses how healthcare professionals can do better at communicating public hea ...  Show more

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and L ...  Show more

Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treat ...

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more